Ligand validation:5VVC

BTB: 2-[BIS-(2-HYDROXY-ETHYL)-AMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5VVC_BTB_A_505	61%	76%	0.139	0.926	0.38	0.55	-	-	6	0	100%	1
5VVC_BTB_B_504	56%	80%	0.141	0.914	0.49	0.36	-	-	0	0	100%	1
5VVC_BTB_A_504	56%	79%	0.175	0.948	0.4	0.47	-	-	4	0	100%	1
5VVC_BTB_D_504	55%	77%	0.121	0.888	0.43	0.48	-	-	6	0	100%	1
5VVC_BTB_B_508	48%	78%	0.183	0.927	0.43	0.45	-	-	8	0	100%	1
5VVC_BTB_D_505	47%	67%	0.198	0.937	0.51	0.77	-	-	3	0	100%	1
5VVC_BTB_C_504	44%	68%	0.206	0.936	0.49	0.73	-	-	3	0	100%	1
5VVC_BTB_A_506	40%	80%	0.159	0.871	0.35	0.48	-	-	4	0	100%	1
5VVC_BTB_C_505	37%	86%	0.172	0.871	0.35	0.38	-	-	2	0	100%	1
5VVC_BTB_B_505	34%	78%	0.222	0.908	0.44	0.46	-	-	9	0	100%	1
5VVC_BTB_C_506	34%	62%	0.151	0.831	0.58	0.88	-	-	10	0	100%	1
9CWK_BTB_B_505	100%	80%	0.025	0.996	0.31	0.53	-	-	2	0	100%	1
9CW6_BTB_C_504	100%	51%	0.028	0.996	0.41	1.45	-	1	4	0	100%	1
9CW4_BTB_C_504	100%	49%	0.032	0.995	0.42	1.5	-	2	2	0	100%	1
9CW9_BTB_D_504	100%	70%	0.036	0.994	0.39	0.76	-	-	1	0	100%	1
5UOB_BTB_B_504	100%	73%	0.038	0.994	0.58	0.47	-	-	3	0	100%	1
5O5D_BTB_A_604	100%	59%	0.022	0.994	0.89	0.68	1	-	2	0	100%	1
8F9X_BTB_J_305	100%	60%	0.032	0.992	0.86	0.66	-	-	5	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.